Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
ID: 351638Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/351638

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-076.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Stephen I. Katz Early Stage Investigator Research Project Grant (R01), aimed at supporting innovative research projects by early-stage investigators (ESIs) that signify a substantial change in research direction without the inclusion of preliminary data. This grant specifically targets basic experimental studies involving human participants, requiring applicants to provide a detailed explanation of how their proposed project diverges from their previous work, while aligning with the scientific missions of participating NIH Institutes and Centers. The funding opportunity encourages diversity and aims to stimulate novel approaches in biomedical research, with applications accepted until December 29, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-076-Full-Announcement.html
    PAR-24-076.html
    The Stephen I. Katz Early Stage Investigator Research Project Grant (R01) aims to support innovative research projects by early-stage investigators (ESIs) that represent a significant change in research direction, specifically those without preliminary data. The funding is intended for basic experimental studies involving human participants and requires a detailed description of how the proposed project diverges from the investigator's past work. Applications must not include preliminary data to qualify. The program encourages diversity and aims to stimulate innovative approaches in biomedical research consistent with participating National Institutes of Health (NIH) institutes' missions. Eligibility extends to various institutions including higher education and non-profit entities, with an emphasis on engaging underrepresented groups. Applications undergo rigorous review, focusing on significance, innovation, and approach. The funding opportunity is open for applications until December 29, 2026, with outlined key dates for submission and review processes. Overall, this grant seeks to foster novel scientific exploration while ensuring compliance with NIH's policies and guidelines.
    Similar Opportunities
    Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required) to support innovative research projects by early stage investigators (ESIs) that represent a significant change in research direction without the inclusion of preliminary data. This grant aims to encourage ESIs to explore new avenues in basic science experimental studies involving human subjects, aligning with NIH's definition of clinical trials. The opportunity emphasizes diversity and inclusivity, inviting applications from a wide range of eligible applicants, including higher education institutions and community-based organizations, with application deadlines extending until December 29, 2026. Interested applicants can find more information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) to support innovative research projects led by early-stage investigators (ESIs) that represent a significant change in research direction without prior preliminary data. Applicants must submit proposals that do not include preliminary data and must describe the proposed shift in research focus, aligning with the missions of participating NIH Institutes and Centers. This grant aims to foster groundbreaking research and promote workforce diversity among ESIs from various backgrounds, including higher education institutions, nonprofits, and local governments. The application period opens on December 29, 2023, with a submission deadline of December 28, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-075.html.
    Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required) to support innovative research projects from early stage investigators (ESIs) that represent a new research direction and do not include preliminary data. Applicants must propose basic science experimental studies involving human participants, which align with NIH's definitions of both clinical trials and basic research, and must include a one-page attachment detailing the change in research direction. This grant opportunity is crucial for advancing fundamental biomedical and behavioral research without immediate application towards processes or products. The application period opens on August 25, 2025, and closes on August 25, 2028, with additional information available at NIH Grants. For inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) for the Stephen I. Katz Early Stage Investigator Research Project Grant (R01), aimed at supporting early stage investigators (ESIs) in initiating research projects that diverge from their previous focus. Applicants must propose innovative research directions that do not build upon prior work, encouraging a shift in methodology, discipline, or therapeutic target, and are advised to consult with program directors regarding their proposals. This grant is crucial for fostering new scientific inquiries and advancing health-related research, with no cost-sharing requirements and an estimated award date of July 1, 2026. Interested applicants can reach out to the Division of Biomedical Research Workforce at NIH via email at nihtrain@mail.nih.gov or by phone at 301-496-0180 for further information, with applications expected to be submitted by September 26, 2025.
    Notice of Intent to Publish a Funding Opportunity Announcement for Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
    National Institutes of Health
    The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) for the Stephen I. Katz Early Stage Investigator Research Project Grant (R01), aimed at supporting early-stage investigators (ESIs) in initiating innovative research projects. Eligible applicants, specifically small businesses, are encouraged to propose research that represents a significant change in their research direction, distinct from their previous work, and must involve basic experimental studies with human participants. This funding opportunity is crucial for advancing basic science research and is expected to open for applications on July 26, 2025, with a closing date of September 26, 2025, and an estimated award date of July 1, 2026. For further inquiries, interested parties can contact the Division of Biomedical Research Workforce at NIH via email at nihtrain@mail.nih.gov or by phone at 301-496-0180.
    Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Supporting Talented Early Career Researchers in Genomics," aimed at supporting innovative research projects led by Early Stage Investigators (ESIs) with a focus on genomics. This initiative encourages diverse applicants to propose research that aligns with the mission of the National Human Genome Research Institute (NHGRI), covering areas such as genomic sciences, genomic medicine, genomic data science, and the ethical implications of genomics. The program has a funding commitment of at least $2 million, with plans to award 3-5 grants, each with an annual budget cap of $400,000. Applications must be submitted electronically by February 26, 2027, and should include a detailed professional development plan and a resource sharing plan in compliance with NIH policies. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESIs), aimed at supporting fundamental, investigator-initiated research within the mission of the National Institute of General Medical Sciences (NIGMS). This grant program is designed to provide funding stability and scientific flexibility, allowing early career researchers to undertake ambitious studies while reducing administrative burdens by consolidating all NIGMS research support into a single award. The MIRA program is crucial for enhancing scientific productivity and fostering breakthroughs in health research, with no cost-sharing or matching requirements. Interested applicants can reach out to Michelle R. Bond, Ph.D. and Marc Rigas, Ph.D. at 301-594-2987 or via email at ESIMIRA@nigms.nih.gov for further information. The estimated project start date is July 1, 2027, with applications expected to close on October 5, 2026.
    Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Maximizing Investigators' Research Award (MIRA) aimed at Early Stage Investigators (ESIs) under the Notice of Funding Opportunity (NOFO) PAR-23-145. This grant supports a comprehensive research program within the mission of the National Institute of General Medical Sciences (NIGMS), allowing eligible researchers to apply for up to $250,000 per year for a maximum of five years, with a requirement to dedicate at least 51% of their research efforts to the program. The MIRA program is designed to enhance scientific productivity and flexibility, enabling early-career scientists to explore significant research projects without the need for preliminary data, while also promoting diversity through a required Plan for Enhancing Diverse Perspectives (PEDP). Interested applicants should note that the application deadline is February 3, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)." This initiative aims to support new investigators from diverse and underrepresented backgrounds in biomedical research, enabling them to conduct small-scale projects that align with the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and other participating institutes. The grants, with a maximum budget of $125,000 per year for a project period not exceeding three years, are intended to facilitate the transition of these researchers toward independence while addressing health disparities. Interested applicants must demonstrate that they have had less than $125,000 in direct costs from combined active research funding and can submit proposals starting in early 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-097.html.
    NIH Exploratory/Developmental Research Project Grant (Parent R21 Basic Experimental Studies with Humans Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Project Grant (Parent R21 Basic Experimental Studies with Humans Required) to support innovative research projects that involve basic experimental studies with human participants. This funding opportunity aims to foster groundbreaking research strategies that can lead to significant advancements in biomedical, behavioral, or clinical research, particularly in understanding fundamental phenomena without immediate application in mind. Grants may be awarded for a total project period of up to two years, with budgets capped at $275,000, and applications are encouraged from a diverse range of eligible applicants, including historically black colleges and universities, faith-based organizations, and other institutions. Interested parties should note that the application deadline is January 7, 2028, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.